| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/24/2003 | US20030077594 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 04/24/2003 | US20030077593 Nucleotide sequences coding polypeptide for use in the treatment of cancer and nervous system disorders |
| 04/24/2003 | US20030077589 Method for in vitro diagnosis of endometriosis |
| 04/24/2003 | US20030077585 Nucleotide sequences coding polypeptide for use in the diagnosis, detection, prevention and treatment of bacterial infection |
| 04/24/2003 | US20030077583 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/24/2003 | US20030077579 Diagnostic assay |
| 04/24/2003 | US20030077578 Diagnostic assay |
| 04/24/2003 | US20030077577 Identification and isolation of novel polypeptides having WW domains and methods of using same |
| 04/24/2003 | US20030077576 Use of monoclonal antibodies and functional assays for prediction of risk of opportunistic infection |
| 04/24/2003 | US20030077573 Methods of identifying compounds useful in the inhibition of neurodegenerative disease |
| 04/24/2003 | US20030077572 Monitoring preferential components of cells; label cells, mix with control, detect, monitor and measure labelled cells |
| 04/24/2003 | US20030077571 Model for use in evaluation and treatment of muscular disorders and asthenopia |
| 04/24/2003 | US20030077568 Screening drugs; obtain cell with preferential phenotypic profile, incubate with drug, monitor effect on cells |
| 04/24/2003 | US20030077305 Administering to a mammal a formualtion comprising cationic lipids/DNA complex, allowing the complex to associate with angiogenic endothelial cells of an angiogenic blood vessel for a time such that the complex enters the target cells |
| 04/24/2003 | US20030077292 Detection and treatment of cancers of the lung |
| 04/24/2003 | US20030077288 Compositions and methods for treatment of muscle wasting |
| 04/24/2003 | US20030077286 A T cell receptor ligand which substantially inhibits at least one T cell effector response evoked by fully active peptide-MHC(major histocompatibility complex) available to respond T cells |
| 04/24/2003 | US20030077285 Methods of diagnosis and treatment by binding p75/airm1 |
| 04/24/2003 | US20030077284 Contacting a B cell antigen receptor, pre-B cell receptor, pro-B cell receptor, Ig Fc receptors, and NK receptors, with a regulatory compound, causes dissociation of extracellular ligand binding component from transducer component |
| 04/24/2003 | US20030077281 Immunointeractive molecules and uses therefor |
| 04/24/2003 | US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells |
| 04/24/2003 | US20030077278 Novel human beta2 integrin alpha subunit |
| 04/24/2003 | US20030077277 Human antibodies that have MN binding and cell adhesion-neutralizing activity |
| 04/24/2003 | US20030077261 Increasing in vivo concentration of A beta peptide, or biologically active fragments or variants thereof within a patient suffering from angiogenic diseases, conditions, or processes |
| 04/24/2003 | US20030077252 Vaccination against plaque forming diseases; inhibiting aggregation of amyloid in mammal and/or to cause disaggregation of amyloid; treating brain disorder, Alzheimer's disease |
| 04/24/2003 | US20030077246 TNFr/OPG-like molecules and uses thereof |
| 04/24/2003 | US20030077222 Individualization of therapy with analgesics |
| 04/24/2003 | US20030076492 Identification of material inclusions in pulp and paper using Raman spectroscopy |
| 04/24/2003 | US20030076487 System and method for glass processing and stress measurement |
| 04/24/2003 | US20030076120 System and method for measuring moisture content in a conductive environment |
| 04/24/2003 | US20030076087 Method and arrangement relating to substance analysis |
| 04/24/2003 | US20030075682 Method for forming composite arrays of single-wall carbon nanotubes and compositions thereof |
| 04/24/2003 | US20030075478 On-line determination of wax crystallization temperature of waxy solvent stream |
| 04/24/2003 | US20030075448 Interdigitated electrochemical gas generator |
| 04/24/2003 | US20030075439 Electrochemical gas sensor with passage for receiving gas |
| 04/24/2003 | US20030075119 Ethanol content rationality for a flexible fueled vehicle |
| 04/24/2003 | US20030074952 Gas sensor and manufacturing method for the same |
| 04/24/2003 | US20030074951 Carbon monooxide detector |
| 04/24/2003 | CA2464373A1 Apparatus and method for detecting undesired residues in a sample |
| 04/24/2003 | CA2463943A1 Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 04/24/2003 | CA2463927A1 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof |
| 04/24/2003 | CA2463925A1 Bone anti-resorptive compounds |
| 04/24/2003 | CA2463920A1 Methods for detecting ovarian cancer |
| 04/24/2003 | CA2463916A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 04/24/2003 | CA2463845A1 Substrate coated with a transparent organic film and method for making same |
| 04/24/2003 | CA2463711A1 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
| 04/24/2003 | CA2463701A1 Continuous on-line carbon analyzer |
| 04/24/2003 | CA2463649A1 Rankl mimics and uses thereof |
| 04/24/2003 | CA2463641A1 Antisense antiviral agent and method for treating ssrna viral infection |
| 04/24/2003 | CA2463596A1 Method of screening cell death inhibitor |
| 04/24/2003 | CA2463581A1 Microfluidized leishmania antigen and methods of making and using thereof |
| 04/24/2003 | CA2463578A1 Differentially expressed genes associated with obesity and type 2 diabetes |
| 04/24/2003 | CA2463573A1 Article dispensing apparatus and method |
| 04/24/2003 | CA2463571A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 04/24/2003 | CA2463492A1 Methods for the treatment of carcinoma |
| 04/24/2003 | CA2463318A1 Methods and apparatuses for analyzing biological samples by mass spectrometry |
| 04/24/2003 | CA2463177A1 Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells |
| 04/24/2003 | CA2463040A1 Nucleic acid amplification methods |
| 04/24/2003 | CA2463017A1 Method for preparation of single chain antibodies |
| 04/24/2003 | CA2462785A1 Kinases and phosphatases |
| 04/24/2003 | CA2462560A1 Systems and methods for performing multiple diagnostic tests |
| 04/24/2003 | CA2462447A1 Article handling system and method |
| 04/24/2003 | CA2461818A1 Treatment and diagnosis of insulin resistant states |
| 04/24/2003 | CA2453264A1 Novel drug targets for arthritis |
| 04/24/2003 | CA2452797A1 Apparatus and method for mixing specimens in vials |
| 04/23/2003 | EP1304574A2 Elisa confirmation test for early primary cytomegalovirus infection |
| 04/23/2003 | EP1304573A1 Method for screening ligand having biological activity |
| 04/23/2003 | EP1304571A1 Method of immunity examination with insoluble carrier particle and reagent therefor |
| 04/23/2003 | EP1304570A1 Electrochemical electrode test strip and process for preparation thereof |
| 04/23/2003 | EP1304569A2 Interdigitated electrochemical gas generator |
| 04/23/2003 | EP1304563A1 Semiconductor device with a multi-layer structure and method for its manufacture |
| 04/23/2003 | EP1304562A1 X-ray inspection system for products, in particular food products |
| 04/23/2003 | EP1304561A1 Probe for visualizing phosphorylation/dephosphorylation of protein and method of detecting and quantifying phosphorylation/dephosphorylation of protein |
| 04/23/2003 | EP1304556A2 Consumable for laser capture microdissection |
| 04/23/2003 | EP1304466A2 Ethanol content rationality for a flexible fueled vehicle |
| 04/23/2003 | EP1304386A1 Method of constructing self-assembly of probes and method of detecting the same |
| 04/23/2003 | EP1304385A1 Method of selectively determining glycated hemoglobin |
| 04/23/2003 | EP1304378A1 ARL-2 for fertility control |
| 04/23/2003 | EP1304336A2 Antibodies for specific detection of pathogenic prions of human origin and detection methods using them |
| 04/23/2003 | EP1304166A1 Flow through reaction chamber with sensor chip |
| 04/23/2003 | EP1303760A2 Methods of identifying the activity of gene products |
| 04/23/2003 | EP1303759A2 Electrochemical immunoassays using colloidal metal markers |
| 04/23/2003 | EP1303758A2 Electrochemical method for measuring chemical reaction rates |
| 04/23/2003 | EP1303757A2 Ion channel assay methods |
| 04/23/2003 | EP1303751A1 Dyes and methods of detection of nucleic acid in immature red blood cells |
| 04/23/2003 | EP1303749A2 Methods using light emission for determining the effectiveness of plant treatment agents in controlling plant disease organisms |
| 04/23/2003 | EP1303746A1 Analysis method and cuvette therefor |
| 04/23/2003 | EP1303639A2 Method of designing addressable array for detection of nucleic acid sequence differences using ligase detection reaction |
| 04/23/2003 | EP1303636A1 Iterative analysis of non-responding population in the design of pharmacogenetic studies |
| 04/23/2003 | EP1303634A2 Relative rates of cytochrome p450 metabolism |
| 04/23/2003 | EP1303620A2 Regulation of human desc1-like serine protease |
| 04/23/2003 | EP1303611A2 Novel protein containing ring finger domaine r1p4 |
| 04/23/2003 | EP1303610A2 Extracellular matrix protein |
| 04/23/2003 | EP1303609A2 G-protein coupled receptors |
| 04/23/2003 | EP1303608A2 Zinc finger domain recognition code and uses thereof |
| 04/23/2003 | EP1303607A2 High affinity soluble interleukin-18 receptor |
| 04/23/2003 | EP1303599A2 Methylated nucleotide regulation of upa gene expression |
| 04/23/2003 | EP1303598A1 Molecular markers |
| 04/23/2003 | EP1303591A2 Masp-2, a complement-fixing enzyme, and uses for it |
| 04/23/2003 | EP1303589A1 Pre-adipose cell lines |